Drug
Ivonescimab Combined With Chemotherapy
Ivonescimab Combined With Chemotherapy: highest development phase Phase 1/2, developed by Akeso. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Akeso
Trials
| Drug | Phase | Indication |
|---|---|---|
| Ivonescimab Combined With Chemotherapy NCT07885319 | Phase 1/2 | Malignant Pleural Mesothelioma, Advanced |
Latest
No recent events.
Follow Ivonescimab Combined With Chemotherapy on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.